Skip header and navigation

Refine By

   MORE

6 records – page 1 of 1.

Cavoatrial extension of renal cell cancer: results of operative treatment in Helsinki University Hospital between 1990 and 2000.

https://arctichealth.org/en/permalink/ahliterature177408
Source
Scand J Surg. 2004;93(3):213-6
Publication Type
Article
Date
2004
Author
A. Rannikko
J. Sipponen
S. Nordling
M. Ruutu
Author Affiliation
Department of Urology, Helsinki University Central Hospital, Helsinki, Finland.
Source
Scand J Surg. 2004;93(3):213-6
Date
2004
Language
English
Publication Type
Article
Keywords
Adult
Aged
Blood Vessel Prosthesis Implantation
Carcinoma, Renal Cell - mortality - pathology
Finland
Heart Atria - pathology
Hospitals, University
Humans
Kidney Neoplasms - mortality - pathology
Neoplastic Cells, Circulating - pathology
Vena Cava, Inferior - pathology - surgery
Abstract
To evaluate the technical procedures and the post-operative survival of patients having been operated for renal cell cancer with cavoatrial tumour thrombus (RCC-T).
Between 1990 and 2000 the cardiac unit at Helsinki University Central Hospital operated on seven patients for RCC-T. A cardiac surgeon along with a urologist, performed all seven operations using sternolaparotomy (either midline or Chevron incision) with cardiopulmonary bypass.
The average duration of the operations was eight hours (range 6-11 hours) and the average perfusion time was 118 minutes (range 35-206). Hypothermic circulatory arrest was used for one patient with an arrest time of 31 minutes. Only with one patient could the cavotomy be closed directly. In four patients a cava resection was performed and closed either with a pericardium patch or a Gore-Tex prosthesis. In two patients the cava was ligated below the renal veins. During the post-operative intensive care, there were two deaths. Of the remaining patients, five were alive after six months, four after 12 months, three after six years and one patient is still alive after 12 years of follow-up.
In agreement with previously published results, although peri-operative mortality is relatively high with RCC-T patients, long-term post-operative survival is possible.
PubMed ID
15544077 View in PubMed
Less detail

[Characteristics of surgical approach using for patients with renal cell carcinoma, complicated by postcava tumor thrombosis].

https://arctichealth.org/en/permalink/ahliterature117722
Source
Vestn Khir Im I I Grek. 2013;172(6):46-50
Publication Type
Article
Date
2013
Author
D A Granov
D N Maistrenko
M I Shkol'nik
A D Belov
E A Belova
V V Osovskikh
Source
Vestn Khir Im I I Grek. 2013;172(6):46-50
Date
2013
Language
Russian
Publication Type
Article
Keywords
Blood Vessel Prosthesis Implantation - methods
Carcinoma, Renal Cell - complications - mortality - pathology - surgery
Female
Humans
Kidney Neoplasms - complications - mortality - pathology - surgery
Male
Middle Aged
Neoplasm Invasiveness
Nephrectomy - methods
Phlebography - methods
Prognosis
Russia
Survival Rate
Thrombectomy - methods
Treatment Outcome
Vena Cava, Inferior - pathology - surgery
Venous Thrombosis - etiology - pathology - surgery
Abstract
The postcava tumor thrombosis had about 1/3 of patients with renal cell carcinoma at the initial examination. Reconstructive interventions were performed on the postcava for 38 patients (24 men, 14 women). The postcava thrombectomy was applied in 15 patients. The thrombectomy with postcava resection were carried out in 13 patients and plasty- in 6, prosthetics-in 4. An actuarial 3-year or 5-year survival rate of patients consisted of 59.4% and 42.2%. The performance of reconstructive interventions on postcava with its involvement was justified and provided satisfactory results in patients with renal cell carcinoma.
PubMed ID
24738202 View in PubMed
Less detail

[Remote results of implantation of cava filters: analysis of errors and complications].

https://arctichealth.org/en/permalink/ahliterature265369
Source
Angiol Sosud Khir. 2015;21(2):53-8
Publication Type
Article
Date
2015
Author
I I Zatevakhin
V N Shipovsky
M A Barzaeva
Source
Angiol Sosud Khir. 2015;21(2):53-8
Date
2015
Language
Russian
Publication Type
Article
Keywords
Female
Femoral Vein - pathology - physiopathology
Humans
Iliac Vein - pathology - physiopathology
Male
Middle Aged
Moscow
Outcome Assessment (Health Care)
Postoperative Complications - diagnosis - etiology - physiopathology - prevention & control
Prosthesis Implantation - adverse effects - methods
Pulmonary Embolism - diagnosis - etiology - physiopathology - prevention & control
Recurrence
Thrombosis - complications - diagnosis - physiopathology - surgery
Vena Cava Filters - adverse effects - classification
Vena Cava, Inferior - pathology - physiopathology - surgery
Abstract
The authors carried out comparative assessment of efficacy of cava filters (CF) for prevention of pulmonary artery thromboembolism in patients presenting with iliofemoral thrombosis with flotation of thrombi, as well as analysed complications in the remote postimplantation period. A total of 266 patients were examined within the terms from 1 month to 10 years after CF implantation. Depending on the type of the implanted device, all patients were subdivided into 3 groups: group 1 (n=65) consisted of patients with one-level CF, group 2 (n=112) comprised those with "sandglass" and "shuttle" type two-level cava filters, and group 3 (n=89) was composed of patients with the implanted CF "TrapEase" and "OptEase". In the remote period relapsed PATE was revealed in 5.2% of cases. Embolism in the CF was noted in 9.3% of cases, with the incidence rate of this complication not depending on the type of the implanted device. However, total occlusion of the inferior vena cava after embolism was observed 2 times more often in patients of the 2nd and 3rd group. In the first group recanalization of the intrafilter space occurred in one third of cases. Chronic occlusion of the inferior vena cava was revealed in 13.9% of cases, most frequently in group 2. Total occlusion of the inferior vena cava with the development of inferior vena cava syndrome was diagnosed in 24.1% of patients with thrombotic lesion below the level of renal veins confluence. This complication was associated with both characteristics of CF and technical errors of implantation, and was also encountered more frequently in group 2.
PubMed ID
26035565 View in PubMed
Less detail

Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis.

https://arctichealth.org/en/permalink/ahliterature71313
Source
Z Rheumatol. 2003 Jun;62(3):246-50
Publication Type
Article
Date
Jun-2003
Author
A A Shahin
H. Mostafa
H. Sami
H A Shahin
Author Affiliation
Department of Rheumatology and Rehabilitation, 453 Al-Ahram Street, Al-Ahram, Giza, Egypt. rughe@rusys.eg.net
Source
Z Rheumatol. 2003 Jun;62(3):246-50
Date
Jun-2003
Language
English
Publication Type
Article
Keywords
Adult
Antibodies, Anticardiolipin - blood
Biopsy
Diagnostic Imaging
Egypt
Female
Humans
Kidney - pathology
Lupus Erythematosus, Systemic - diagnosis - pathology
Lupus Nephritis - diagnosis - pathology
Male
Nephrotic Syndrome - diagnosis - pathology
Renal Veins - pathology
Risk factors
Thrombosis - diagnosis - pathology
Vena Cava, Inferior - pathology
Abstract
OBJECTIVE: To evaluate the prevalence of symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus (SLE), and to evaluate the frequency and the risk factors associated with renal vein thrombosis in those patients. METHODS: Fifty-four patients with SLE, 51 (94.4%) females, were involved in this study. All of them were submitted for abdominal sonography, chest X-ray, echocardiography, and Doppler of renal, abdominal and lower limb veins, with examination of data on clinical and laboratory profile. Abdominal CT, brain MRI, MRI both hips, CT chest and pulmonary scintigraphy were used when needed. RESULTS: Sixteen patients (29.6%) were diagnosed with symptomatic thrombotic events. Eight patients had more than one type of thrombosis. Two patients (3.7%) were diagnosed by Doppler as having renal vein thrombosis (RVT). This was confirmed by abdominal CT. One of them presented with nephrotic syndrome, graded by renal biopsy as World Health Organization (WHO) class V, and had positive anticardiolipin antibodies (ACL). The other patient had RVT and inferior vena cava (IVC) thrombosis, nephrotic syndrome, positive ACL, and died before renal biopsy was performed. Both of them were without history of peripheral thrombotic events. One patient was diagnosed with IVC thrombosis, lupus nephritis grade II, positive ACL, and diagnosed by abdominal CT. One patient was diagnosed with portal vein thrombosis and had positive ACL. One patient with retinal vessel thrombosis and positive ACL. Four patients had deep vein thrombosis (DVT). Recurrent miscarriages were reported in 4 patients (7.4%), skin ulcerations in 3 (5.6%), avascular necrosis of the hips in 4 (7.4%), stroke in 1 (1.9%), and pulmonary hypertension in 2 patients (3.7%). CONCLUSION: Sixteen SLE patients (29.6%) were diagnosed with symptomatic thrombotic events. RVT was detected in 2 patients representing 3.7% of all patients, and 12.5% of patients with thrombosis. Both patients with RVT presented with nephrotic syndrome.
PubMed ID
12827401 View in PubMed
Less detail

[Thrombectomy and plication of veins as a method of preventing pulmonary artery thromboembolism at a multidisciplinary surgical hospital].

https://arctichealth.org/en/permalink/ahliterature275526
Source
Angiol Sosud Khir. 2016;22(2):85-9
Publication Type
Article
Date
2016
Author
S V Galkin
N V Pashin
I G Dedyukhin
A G Aleksandrov
M V Lebedeva
Source
Angiol Sosud Khir. 2016;22(2):85-9
Date
2016
Language
Russian
Publication Type
Article
Keywords
Adult
Aged
Female
Humans
Iliac Vein - pathology - surgery
Lower Extremity - blood supply
Male
Middle Aged
Postoperative Complications - prevention & control
Pregnancy
Pulmonary Embolism - diagnosis - etiology - prevention & control
Retrospective Studies
Russia
Thrombectomy - methods
Tomography, X-Ray Computed
Ultrasonography, Doppler, Duplex - methods
Vena Cava, Inferior - pathology - surgery
Venous Insufficiency - etiology - prevention & control
Venous Thrombosis - complications - diagnosis - surgery
Abstract
The authors assessed efficacy and safety of the operation of plication of deep veins of lower extremities, pelvic veins, and the inferior vena cava as a method of preventing fatal pulmonary artery thromboembolism. A total of 48 patients were operated on. Of these, 23 patients belonged to traumatological-and-orthopaedical cohort, 3 to general surgical cohort, 4 to gynaecological, and 18 to vascular cohort (isolated deep vein thrombosis). The length of the floating head of the thrombus varied from 2 to 10 cm. The presence of a floating thrombus in traumatological, surgical and gynaecological patients, regardless of the length of the floating part was an absolute indication for thrombectomy and venous plication. Vascular patients were operated on in accordance with the National Guidelines (with the length of the thrombus floating portion of not less than 4 cm). In all cases, surgical management envisaged direct and indirect thrombectomy. Plication was always performed above the level of venotomy. It was shown that thrombectomy combined with plication of major veins is a reliable and safe method of prophylaxis, being in some cases the only possible method of preventing fatal pulmonary artery thromboembolism. The operation of plication makes it possible not to cancel a scheduled surgical intervention in patients with a detected floating thrombus of major veins. The operation of thrombectomy and plication above the level of the floating head of the thrombus may be considered an operation of choice in the conditions where there is no possibility to use endovascular methods of treatment (implantation of a cava filter, endovascular catheter thrombectomy), as well as in pregnant women. Restoration of the venous lumen occurs at safe terms spontaneously, not requiring repeat surgical intervention. Simultaneous plication of the vein does not complicate the course of the postoperative period of the main surgical intervention. Thrombectomy and plication do not lead to the development of severe chronic venous insufficiency.
PubMed ID
27336339 View in PubMed
Less detail

Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. Case report.

https://arctichealth.org/en/permalink/ahliterature19813
Source
Drugs Exp Clin Res. 2000;26(5-6):257-9
Publication Type
Article
Date
2000
Author
O L Prokopchuk
S V Zemskov
Y M Susak
Author Affiliation
Kiev Centre of Hepato-Pancreato-Biliary Surgery, Kiev, Ukraine.
Source
Drugs Exp Clin Res. 2000;26(5-6):257-9
Date
2000
Language
English
Publication Type
Article
Keywords
Alkaloids - adverse effects - therapeutic use
Antineoplastic Agents, Phytogenic - adverse effects - therapeutic use
Carcinoma, Renal Cell - drug therapy - pathology - surgery
Combined Modality Therapy
Humans
Immunity, Cellular - drug effects
Kidney Neoplasms - drug therapy - pathology - surgery
Male
Middle Aged
Quality of Life
Vascular Neoplasms - drug therapy - secondary - surgery
Vena Cava, Inferior - pathology
Abstract
A 52-year-old man with renal cell carcinoma was treated with surgery and chemotherapy (vinblastine). Ukrain was administered after tumor progression to the vena cava inferior and appearance of liver metastasis. The drug induced a complete remission, which has lasted 32 months since the first therapy course.
PubMed ID
11345035 View in PubMed
Less detail

6 records – page 1 of 1.